A pilot study assessing social support among cancer patients enrolled on clinical trials: A comparison of younger versus older adults

Paul J. Novotny, Denise J. Smith, Lorna Guse, Teresa A. Rummans, Lynn Hartmann, Steven Robert Alberts, Richard Goldberg, David Gregory, Mary Johnson, Jeff A Sloan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: This study tested the logistical feasibility of obtaining data on social support systems from cancer patients enrolled on clinical trials and compared the social support of older adults (age >65) and younger adults (<50 years of age) with cancer. Methods: Patients had to be eligible for a phase II or phase III oncology clinical trial and enter the study prior to treatment. Patients filled out the Lubben Social Network Scale (LSNS) at baseline. The Symptom Distress Scale (SDS) and single-item overall quality of life (QOL) Uniscale were assessed at baseline and weekly for 4 weeks. Results: There was no significant difference in overall mean Lubben social support levels by age. Older patients had more relatives they felt close to (85% versus 53% with 5 or more relatives, P = 0.02), heard from more friends monthly (84% versus 53% with 3 or more friends, P = 0.02), less overall symptom distress (P = 0.03), less insomnia (P = 0.003), better concentration (P = 0.005), better outlook (P = 0.01), and less depression (P = 0.005) than younger patients. Conclusions: Younger subjects reported worse symptoms, a smaller social support network, and fewer close friends and relatives than older subjects. Having someone to discuss decisions and seeing friends or relatives often was associated with longer survival.

Original languageEnglish (US)
Pages (from-to)133-142
Number of pages10
JournalCancer Management and Research
Volume2
Issue number1
StatePublished - 2010

Fingerprint

Social Support
Clinical Trials
Neoplasms
Phase III Clinical Trials
Sleep Initiation and Maintenance Disorders
Young Adult
Quality of Life
Depression
Survival

Keywords

  • Elderly
  • Lubben scale
  • QOL
  • Social support

ASJC Scopus subject areas

  • Oncology

Cite this

A pilot study assessing social support among cancer patients enrolled on clinical trials : A comparison of younger versus older adults. / Novotny, Paul J.; Smith, Denise J.; Guse, Lorna; Rummans, Teresa A.; Hartmann, Lynn; Alberts, Steven Robert; Goldberg, Richard; Gregory, David; Johnson, Mary; Sloan, Jeff A.

In: Cancer Management and Research, Vol. 2, No. 1, 2010, p. 133-142.

Research output: Contribution to journalArticle

Novotny, PJ, Smith, DJ, Guse, L, Rummans, TA, Hartmann, L, Alberts, SR, Goldberg, R, Gregory, D, Johnson, M & Sloan, JA 2010, 'A pilot study assessing social support among cancer patients enrolled on clinical trials: A comparison of younger versus older adults', Cancer Management and Research, vol. 2, no. 1, pp. 133-142.
Novotny, Paul J. ; Smith, Denise J. ; Guse, Lorna ; Rummans, Teresa A. ; Hartmann, Lynn ; Alberts, Steven Robert ; Goldberg, Richard ; Gregory, David ; Johnson, Mary ; Sloan, Jeff A. / A pilot study assessing social support among cancer patients enrolled on clinical trials : A comparison of younger versus older adults. In: Cancer Management and Research. 2010 ; Vol. 2, No. 1. pp. 133-142.
@article{6037186fb2154df0862479754dc789de,
title = "A pilot study assessing social support among cancer patients enrolled on clinical trials: A comparison of younger versus older adults",
abstract = "Purpose: This study tested the logistical feasibility of obtaining data on social support systems from cancer patients enrolled on clinical trials and compared the social support of older adults (age >65) and younger adults (<50 years of age) with cancer. Methods: Patients had to be eligible for a phase II or phase III oncology clinical trial and enter the study prior to treatment. Patients filled out the Lubben Social Network Scale (LSNS) at baseline. The Symptom Distress Scale (SDS) and single-item overall quality of life (QOL) Uniscale were assessed at baseline and weekly for 4 weeks. Results: There was no significant difference in overall mean Lubben social support levels by age. Older patients had more relatives they felt close to (85{\%} versus 53{\%} with 5 or more relatives, P = 0.02), heard from more friends monthly (84{\%} versus 53{\%} with 3 or more friends, P = 0.02), less overall symptom distress (P = 0.03), less insomnia (P = 0.003), better concentration (P = 0.005), better outlook (P = 0.01), and less depression (P = 0.005) than younger patients. Conclusions: Younger subjects reported worse symptoms, a smaller social support network, and fewer close friends and relatives than older subjects. Having someone to discuss decisions and seeing friends or relatives often was associated with longer survival.",
keywords = "Elderly, Lubben scale, QOL, Social support",
author = "Novotny, {Paul J.} and Smith, {Denise J.} and Lorna Guse and Rummans, {Teresa A.} and Lynn Hartmann and Alberts, {Steven Robert} and Richard Goldberg and David Gregory and Mary Johnson and Sloan, {Jeff A}",
year = "2010",
language = "English (US)",
volume = "2",
pages = "133--142",
journal = "Cancer Management and Research",
issn = "1179-1322",
publisher = "Dove Medical Press Ltd.",
number = "1",

}

TY - JOUR

T1 - A pilot study assessing social support among cancer patients enrolled on clinical trials

T2 - A comparison of younger versus older adults

AU - Novotny, Paul J.

AU - Smith, Denise J.

AU - Guse, Lorna

AU - Rummans, Teresa A.

AU - Hartmann, Lynn

AU - Alberts, Steven Robert

AU - Goldberg, Richard

AU - Gregory, David

AU - Johnson, Mary

AU - Sloan, Jeff A

PY - 2010

Y1 - 2010

N2 - Purpose: This study tested the logistical feasibility of obtaining data on social support systems from cancer patients enrolled on clinical trials and compared the social support of older adults (age >65) and younger adults (<50 years of age) with cancer. Methods: Patients had to be eligible for a phase II or phase III oncology clinical trial and enter the study prior to treatment. Patients filled out the Lubben Social Network Scale (LSNS) at baseline. The Symptom Distress Scale (SDS) and single-item overall quality of life (QOL) Uniscale were assessed at baseline and weekly for 4 weeks. Results: There was no significant difference in overall mean Lubben social support levels by age. Older patients had more relatives they felt close to (85% versus 53% with 5 or more relatives, P = 0.02), heard from more friends monthly (84% versus 53% with 3 or more friends, P = 0.02), less overall symptom distress (P = 0.03), less insomnia (P = 0.003), better concentration (P = 0.005), better outlook (P = 0.01), and less depression (P = 0.005) than younger patients. Conclusions: Younger subjects reported worse symptoms, a smaller social support network, and fewer close friends and relatives than older subjects. Having someone to discuss decisions and seeing friends or relatives often was associated with longer survival.

AB - Purpose: This study tested the logistical feasibility of obtaining data on social support systems from cancer patients enrolled on clinical trials and compared the social support of older adults (age >65) and younger adults (<50 years of age) with cancer. Methods: Patients had to be eligible for a phase II or phase III oncology clinical trial and enter the study prior to treatment. Patients filled out the Lubben Social Network Scale (LSNS) at baseline. The Symptom Distress Scale (SDS) and single-item overall quality of life (QOL) Uniscale were assessed at baseline and weekly for 4 weeks. Results: There was no significant difference in overall mean Lubben social support levels by age. Older patients had more relatives they felt close to (85% versus 53% with 5 or more relatives, P = 0.02), heard from more friends monthly (84% versus 53% with 3 or more friends, P = 0.02), less overall symptom distress (P = 0.03), less insomnia (P = 0.003), better concentration (P = 0.005), better outlook (P = 0.01), and less depression (P = 0.005) than younger patients. Conclusions: Younger subjects reported worse symptoms, a smaller social support network, and fewer close friends and relatives than older subjects. Having someone to discuss decisions and seeing friends or relatives often was associated with longer survival.

KW - Elderly

KW - Lubben scale

KW - QOL

KW - Social support

UR - http://www.scopus.com/inward/record.url?scp=77955360593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955360593&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77955360593

VL - 2

SP - 133

EP - 142

JO - Cancer Management and Research

JF - Cancer Management and Research

SN - 1179-1322

IS - 1

ER -